Chimeric Therapeutics Ltd：FY26财务报告预计将包含持续经营重大不确定性

65
3
Favorite

Chimeric Therapeutics Ltd：FY26财务报告预计将包含持续经营重大不确定性

美股速递08-19 07:10

Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（3）

andrew123
·2023-03-09
Like
Reply
Like
Report
Huatttah
·2023-03-08
Ok
Reply
4
Report
NPC69
·2023-03-08
K
Reply
5
Report

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1121509471?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-08-19 07:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121509471","market":"us","top_or_hot":-1,"title":"Chimeric Therapeutics Ltd：FY26财务报告预计将包含持续经营重大不确定性","media":"美股速递","content":"<p>Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chimeric Therapeutics Ltd：FY26财务报告预计将包含持续经营重大不确定性</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChimeric Therapeutics Ltd：FY26财务报告预计将包含持续经营重大不确定性\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-08-19 07:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7067","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1121509471","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121509471","pubTimestamp":1787094609,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK7067":"生物科技","CHM.AU":"CHIMERIC THERAPEUTICS LTD"},"translate_title":"英伟达：投资者要小心了，因为估值变得荒谬了","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHM.AU":1},"content_text":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":9949987673,"gmtCreate":1678314506593,"gmtModify":1678317712601,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"idStr":"3576260758860416","authorIdStr":"3576260758860416"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949987673","repostId":1121509471,"repostType":4,"repost":{"id":"1121509471","kind":"news","weMediaInfo":{"introduction":"全球快讯第一时间播报","home_visible":1,"media_name":"美股速递","id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1787094609,"share":"https://ttm.financial/m/news/1121509471?lang=en_US&edition=fundamental","pubTime":"2026-08-19 07:10","market":"us","language":"zh","title":"Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1121509471","media":"美股速递","summary":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","content":"<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time smaller\">2026-08-19 07:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK7067":"生物科技","CHM.AU":"CHIMERIC THERAPEUTICS LTD"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121509471","content_text":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","news_type":1,"symbols_score_info":{"CHM.AU":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949992710,"gmtCreate":1678285768130,"gmtModify":1678285772071,"author":{"id":"3582020329880330","authorId":"3582020329880330","name":"Huatttah","avatar":"https://community-static.tradeup.com/news/789254fa2844c01ae8426d599163e26e","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"idStr":"3582020329880330","authorIdStr":"3582020329880330"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949992710","repostId":1121509471,"repostType":4,"repost":{"id":"1121509471","kind":"news","weMediaInfo":{"introduction":"全球快讯第一时间播报","home_visible":1,"media_name":"美股速递","id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1787094609,"share":"https://ttm.financial/m/news/1121509471?lang=en_US&edition=fundamental","pubTime":"2026-08-19 07:10","market":"us","language":"zh","title":"Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1121509471","media":"美股速递","summary":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","content":"<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time smaller\">2026-08-19 07:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK7067":"生物科技","CHM.AU":"CHIMERIC THERAPEUTICS LTD"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121509471","content_text":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","news_type":1,"symbols_score_info":{"CHM.AU":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949998857,"gmtCreate":1678283452679,"gmtModify":1678283456418,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":12,"crmLevelSwitch":0,"wearingBadges":[],"idStr":"3584779133668268","authorIdStr":"3584779133668268"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949998857","repostId":1121509471,"repostType":4,"repost":{"id":"1121509471","kind":"news","weMediaInfo":{"introduction":"全球快讯第一时间播报","home_visible":1,"media_name":"美股速递","id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1787094609,"share":"https://ttm.financial/m/news/1121509471?lang=en_US&edition=fundamental","pubTime":"2026-08-19 07:10","market":"us","language":"zh","title":"Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1121509471","media":"美股速递","summary":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","content":"<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChimeric Therapeutics Ltd: FY26 Financial Report Expected to Include Material Going Concern Uncertainty\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time smaller\">2026-08-19 07:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Chimeric Therapeutics Ltd (Chimeric Therapeutics Ltd) issued an announcement stating that its fiscal 2026 financial report is expected to cover a material uncertainty related to going concern. The news reveals the serious challenges the company may face in terms of future operational continuity. According to the announcement, the existence of this uncertainty may have a substantial impact on the company's ability to maintain normal business operations. Investors need to pay close attention to this development to assess the company's future financial soundness and sustainable operating prospects.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK7067":"生物科技","CHM.AU":"CHIMERIC THERAPEUTICS LTD"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121509471","content_text":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","news_type":1,"symbols_score_info":{"CHM.AU":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":false,"newsSizeData":{"likeSize":65,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}